Pharmaroth Labs Stock Performance
| ROTH Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pharmaroth Labs are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pharmaroth Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Pharmaroth Labs is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 5:1 | Last Split Date 2010-06-01 |
1 | Aviat Networks to Host Fireside Chat and Participate in 14th Annual Roth Technology Conference | 11/17/2025 |
2 | 4 Moves Retirees Need To Make Now To Prepare for 2026 Tax Rules | 12/02/2025 |
3 | Suze Orman Why You Shouldnt Overlook This Retirement Planning Benefit | 12/15/2025 |
4 | ROTH STAFFING WINS CLEARLYRATEDS 2026 BEST OF STAFFING EMPLOYEE AWARD FOR SERVICE EXCELLENCE | 02/03/2026 |
Pharmaroth | Build AI portfolio with Pharmaroth Stock |
Pharmaroth Labs Relative Risk vs. Return Landscape
If you would invest 0.01 in Pharmaroth Labs on November 7, 2025 and sell it today you would earn a total of 0.00 from holding Pharmaroth Labs or generate 0.0% return on investment over 90 days. Pharmaroth Labs is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Pharmaroth, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pharmaroth Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmaroth Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmaroth Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharmaroth Labs generated a negative expected return over the last 90 days | |
| Pharmaroth Labs has some characteristics of a very speculative penny stock | |
| Pharmaroth Labs has a very high chance of going through financial distress in the upcoming years | |
| Pharmaroth Labs currently holds 853.53 K in liabilities. Pharmaroth Labs has a current ratio of 0.24, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmaroth Labs' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 181.56 K. Net Loss for the year was (91.52 K) with profit before overhead, payroll, taxes, and interest of 80.48 K. | |
| Pharmaroth Labs currently holds about 33 in cash with (17.6 K) of positive cash flow from operations. | |
| Pharmaroth Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: ROTH STAFFING WINS CLEARLYRATEDS 2026 BEST OF STAFFING EMPLOYEE AWARD FOR SERVICE EXCELLENCE |
Pharmaroth Labs Fundamentals Growth
Pharmaroth Stock prices reflect investors' perceptions of the future prospects and financial health of Pharmaroth Labs, and Pharmaroth Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmaroth Stock performance.
| Profit Margin | (2.79) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 1.42 M | ||||
| Shares Outstanding | 149.35 M | ||||
| Price To Earning | (1.22) X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 181.56 K | ||||
| Gross Profit | 80.48 K | ||||
| Net Income | (91.52 K) | ||||
| Cash And Equivalents | 33 | ||||
| Total Debt | 853.53 K | ||||
| Current Ratio | 0.24 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (17.6 K) | ||||
| Market Capitalization | 14.94 K | ||||
| Total Asset | 304.05 K | ||||
| Retained Earnings | (2.89 M) | ||||
| Working Capital | (493 K) | ||||
| Current Asset | 207 K | ||||
| Current Liabilities | 700 K | ||||
About Pharmaroth Labs Performance
By evaluating Pharmaroth Labs' fundamental ratios, stakeholders can gain valuable insights into Pharmaroth Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmaroth Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmaroth Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 453.71 | 476.40 | |
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | 0.16 | 0.15 | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | 0.19 | 0.18 |
Things to note about Pharmaroth Labs performance evaluation
Checking the ongoing alerts about Pharmaroth Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharmaroth Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmaroth Labs generated a negative expected return over the last 90 days | |
| Pharmaroth Labs has some characteristics of a very speculative penny stock | |
| Pharmaroth Labs has a very high chance of going through financial distress in the upcoming years | |
| Pharmaroth Labs currently holds 853.53 K in liabilities. Pharmaroth Labs has a current ratio of 0.24, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmaroth Labs' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 181.56 K. Net Loss for the year was (91.52 K) with profit before overhead, payroll, taxes, and interest of 80.48 K. | |
| Pharmaroth Labs currently holds about 33 in cash with (17.6 K) of positive cash flow from operations. | |
| Pharmaroth Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from prnewswire.com: ROTH STAFFING WINS CLEARLYRATEDS 2026 BEST OF STAFFING EMPLOYEE AWARD FOR SERVICE EXCELLENCE |
- Analyzing Pharmaroth Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmaroth Labs' stock is overvalued or undervalued compared to its peers.
- Examining Pharmaroth Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmaroth Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmaroth Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmaroth Labs' stock. These opinions can provide insight into Pharmaroth Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmaroth Stock analysis
When running Pharmaroth Labs' price analysis, check to measure Pharmaroth Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmaroth Labs is operating at the current time. Most of Pharmaroth Labs' value examination focuses on studying past and present price action to predict the probability of Pharmaroth Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmaroth Labs' price. Additionally, you may evaluate how the addition of Pharmaroth Labs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |